Fusogenic Liposome can be Used as an Effective Vaccine Carrier for Peptide Vaccination to Induce Cytotoxic T Lymphocyte (CTL) Response

Toshiki Sugita, Tomoaki Yoshikawa, Jianqing Gao, Mariko Shimokawa, Atushi Oda, Takako Niwa, Mitsuru Akashi, Yasuo Tsutsumi, Tadanori Mayumi, Shinsaku Nakagawa

Biological and Pharmaceutical Bulletin · 2005 · 12 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

We reported previously that fusogenic liposome (FL) introduced antigen protein encapsulated in the liposome directly into the cytoplasm of the antigen presenting cells, and that it induced immune responses. In the present study, we encapsulated TAX38-46, an HTLV-I derived protein and an antigen peptide model, into FL. The ability to induce effective cytotoxic T lymphocytes (CTL) responses in immunized mice was evaluated. Results showed FL could induce CTL response effectively and suggested that FL is a potential peptide vaccine carrier.

References

9